BACKGROUND
According to the International Labor Office, shift work is defined as “a method of organization of working time in which workers succeed one another at the workplace so that the establishment can operate longer than the hours of work of individual workers” [
1]. More generally, the term is used to encompasses any shift that occurs outside regular daytime hours, with night work regarded as taking place from 22:00 to 06:00 [
2].
Health problems associated with shift work include sleep disorders, mental health issues (such as depression), gastrointestinal complications, and injury, with the most severe symptoms typically being associated with night shifts. In recent years, cerebral cardiovascular disease and cancer have been added to the wide range of negative health outcomes attributed to shift work [
3].
Numerous studies have examined the relationship between cardiovascular diseases and shift work. In a meta-analysis by Bøggild et al. [
4] which reviewed 17 studies (9 cohort studies, 4 case-report studies, and 4 cross-sectional studies) performed prior to 1999, shift workers had a 40% increased risk of cardiovascular disease relative to controls. More recently, Torquati et al. [
5] reviewed 21 studies involving 173,010 unique participants, and found that the risk of any cardiovascular disease event was 17% higher among shift workers compared to daytime workers. Furthermore, the risk of coronary heart disease-related morbidity was 26% higher than that seen in daytime workers.
Shift work-related pathology is typically attributed to circadian stress, in which disruption of the normal circadian rhythms can lead to the dysregulation of normal physiological, behavioral, and psychosocial pathways. Over long periods, these disruptions can lead to a host of chronic diseases, such as atherosclerosis and metabolic syndrome, and may increase the risk of cardiovascular diseases [
4].
Emerging research examining the processes underlying atherosclerosis and inflammatory biomarkers has provided direct evidence of a link between atherosclerosis and shift work [
6]. One such risk factor for cardiovascular disease is plasma homocysteine levels. Homocysteine is a non-proteinogenic amino acid produced during metabolism of the essential amino acid methionine. In addition, homocysteine can be re-synthesized into methionine by a re-methylation process, in which vitamin B
12 acts as a cofactor [
7]. Increased levels of plasma homocysteine are important in cardiovascular disease, increasing the risk associated with factors such as smoking, hypertension, and hyperlipidemia [
8]. Homocysteine levels are also associated with oxidative stress and endothelial dysfunction [
9]; however, the exact role of homocysteine in disease pathogenesis is still controversial. Despite this, the association between hyperhomocysteinemia and cardiovascular disease is strongly supported by epidemiological studies, which have consistently identified hyperhomocysteinemia as an independent risk factor for cardiovascular diseases [
10].
While homocysteine is understood to cause cardiovascular disease, little is known regarding the relationships among plasma homocysteine levels, shift work and cardiovascular disease. Here, we used data from workers' health examinations conducted by a steel company to investigate the association between shift work and cardiovascular disease.
DISCUSSION
The major finding of this study was that the risk of hyperhomocysteinemia was significantly higher for long-term shift workers compared to their day-time counterparts. Numerous independent risk factors for cardiovascular disease, such as smoking, SBP, and TG, were also significantly more prevalent in shift workers compared to daytime workers. Other covariates, including mean age, hypertension, DM, family history of CVA, smoking, SBP, DBP, TG, fasting glucose level, and HbA1C were all significantly higher in long-term shift workers compared with daytime workers. Importantly, the increase in hyperhomocysteinemia among long-term shift workers compared to daytime workers remained statistically significant even after adjusting for these cofactors. Hyperhomocysteinemia increases the risk of cardiovascular disease. In other words, this study confirmed that long-term shift work increases the risk of cardiovascular disease. These results are consistent with the conclusion of Bøggild et al. [
4] who found that the pathological mechanism underlying the association between hyperhomocysteinemia and cardiovascular disease was changes in the natural circadian rhythms brought about by irregular sleep. Furthermore, with the appearance of hyperglycemia, other conditions, such as dyslipidemia and abdominal obesity, may occur due to changes in normal lipid and carbohydrate metabolism. In addition, greater consumption of coffee, cigarettes, alcohol, hypnotic drugs, and a sedentary lifestyle may arise as a result of altered social and family support, as perceived by these workers due to their irregular work hours.
Although shift work and homocysteine levels are both independent risk factors for cardiovascular disease, few studies have directly examined homocysteine levels among shift workers. In 2003, a study examined homocysteine levels in a cohort of bus drivers consisting of 30 male shift workers and 22 control daytime workers in Brazil. Shift working bus drivers had significantly higher plasma homocysteine levels compared to the control group (18.57 vs. 9.43 μmol) [
14]. A similar study of workers at the Israel Electric Company in 2007 assessed 129 shift workers and 173 daytime workers for serum factors, including homocysteine. The mean level of homocysteine in shift workers who complained about sleep disturbances and were over 40 years of age was 19.54 mmol/L, with one-third of workers exhibiting plasma homocysteine concentrations > 15 mmol/L, indicative of hyperhomocysteinemia [
15]. In this study, there was no difference in mean homocysteine concentrations between the shift work or age groups, although the risk of hyperhomocysteinemia was significantly higher in long-term shift workers compared to their daytime counterparts.
Homocysteine is an independent risk factor for cardiovascular disease, similar to other factors, such as blood lipids, diabetes, and hypertension. In 1969, after McCully [
16] published results describing the autopsy of a child with hyperhomocysteinemia and hyperhomocysteinuria as a result of systemic atherosclerosis, numerous studies examining the toxicity of homocysteine in the vascular system have been carried out. Hyperhomocysteinemia has been shown to affect arterial wall remodeling, which could lead to vascular damage. Furthermore, elevated homocysteine levels may enhance oxidative stress and inflammation of vascular endothelial cells, reducing the production and bioavailability of nitric oxide, a strong vasodilator produced by the endothelium. Alternatively, the enhanced arterial stiffness seen in hyperhomocysteinemia may be attributed to the effects of homocysteine atherogenesis, via the production of small particles of low-density lipoprotein [
17]. These effects, along with other factors, constitute strong evidence that oxidation is a major factor underlying the effects of increased homocysteine on atherosclerosis [
18]. Given this litany of deleterious effects on vascular function, homocysteine is now considered an independent risk factor for cardiovascular disease. This was well supported by a systematic review and meta-analysis, which found that an increase in the homocysteine level of 5 μmol/L was associated with an almost 20% increase in disease morbidity, independent of other risk factors for coronary heart disease [
19]. Significant associations between homocysteine and clinical outcomes are usually observed for homocysteine levels greater than 15 μmol/L [
20]; however, there is evidence of a continuous dose-dependent effect, with no apparent threshold concentration for most conditions [
21]. In this study, hyperhomocysteinemia was defined as a homocysteine level above 15 μmol/L [
13], as suggested by the AHA guidelines.
Several factors related to homocysteine levels have been documented. Age, male sex, smoking, coffee consumption, high blood pressure, unfavorable lipid profile, high creatinine level, and methyltetrahydrofolate reductase (MTHFR) gene expression are all factors associated with increased homocysteine levels, while physical activity, moderate alcohol consumption, and a good folate or vitamin B
12 status have been associated with lower homocysteine levels [
22]. Given these risk factors for increased homocysteine levels, there are a number of possible explanations for the increased prevalence of hyperhomocysteinemia in long-term shift workers.
Shift work is stressful and associated with continuous desynchronization and readjustment of circadian rhythms by the hypothalamus [
23]. A previous study demonstrated a 24-hour oscillation in plasma homocysteine concentrations, with a nocturnal peak and a daytime nadir [
24]. Although the exact times were not recorded, most health checks and blood sampling were conducted between 08:00 and 11:00. Interruption of the sleep/wake cycle can alter the overall increase in homocysteine concentrations or move the nocturnal peak to morning hours [
15]. Also, exposure to light at any time suppresses pineal melatonin production in humans [
25]. Of note, increased plasma concentrations of homocysteine and decreased melatonin levels have been reported in rats after pinealectomy, while exogenous melatonin treatment restored basal concentrations [
26]. Thus, a shift work-related decrease in melatonin secretion may also contribute to increased plasma homocysteine concentrations.
In considering the relationship between shift work and clinical outcomes, it is important to determine whether shift work itself is merely a trigger for other lifestyle-related health effects related to coronary heart disease. Risk factors of deleterious socio-temporal patterns and behaviors, including smoking, diet, alcohol, and exercise levels, are all significantly more common among shift workers [
2127], and may themselves lead to cardiovascular disease [
4]. As smoking and coffee consumption increase homocysteine, they have a greater impact on the rise of homocysteine levels in shift workers [
2829]. In this study, coffee consumption, heavy drinking, and regular exercise levels did not differ significantly between shift workers and controls, although the proportion of current smokers was significantly higher in the former group. It is therefore possible that some lifestyle habits associated with shift work may contribute to changes in homocysteine levels.
While homocysteine production is important, degradation of this compound is equally important for determining baseline plasma concentrations. Under normal conditions, homocysteine is metabolized by two major pathways. When methionine is excessive, homocysteine is directed to the transsulfuration pathway, where it is irreversibly conjugated to cysteine by cystathionine B-synthase with vitamin B
6 as a cofactor. Alternatively, homocysteine can also be remethylated in a methionine-conserving pathway. This process requires methionine synthase, vitamin B
12 as a cofactor, and methyltetrahydrofolate as a co-substrate. The methionine-conserving pathway requires folic acid and MTHFR [
27]. Deficiencies in any of the above enzymes, folic acid, or the cofactors may lead to some degree of hyperhomocysteinemia [
30]. As shift workers generally have shorter meal times and are more likely to eat out, they are also more likely to choose convenient foods rich in carbohydrates and lipids. Furthermore, unlike a diet rich in vegetables and fruit, the foods they consume do not contain adequate amounts of B vitamins and folic acids, which can result in increased homocysteine levels.
In general, serum homocysteine levels > 15 μmol/L are considered clinically abnormal; this threshold was therefore chosen as the baseline for determining hyperhomocysteinemia in this study [
1320]. The percentage of workers in this study with hyperhomocysteinemia was 44%, reaching as high as 52.9% in the long-term shift work group. Data from the Framingham study showed that the prevalence of hyperhomocysteinemia was 29.3% for the entire cohort [
31]. In another study examining 103 healthy college students in South Korea, hyperhomocysteinemia was observed in 44% of all students, including 54% of males [
32]. While the concentrations of homocysteine observed in this study did seem to be a little higher than expected, these levels were not significantly different from previous studies. One explanation for this apparent discrepancy may be that homocysteine levels are typically higher in men than in women [
2133]. Since this study examined only male workers, the rate of hyperhomocysteinemia is likely not reflective of the population as a whole.
In general, the factors affecting cardiovascular diseases are highly correlated with age. Furthermore, workers who have performed shift work for long periods are invariably older than their less-experienced coworkers. For this reason, increased homocysteine levels might be thought of as an effect of age rather than of shift work. However, on analyzing the rates of hyperhomocysteinemia and homocysteine concentrations by age, we found no significant difference among groups. Therefore, we were able to control for the effects of age effectively, enabling us to conclude that the prevalence of hyperhomocysteinemia was significantly higher among long-term shift workers.
This study enrolled subjects from representative departments of a large corporation (i.e., only mill and rolling departments) to increase the homogeneity of the study group. Since the type of work can vary depending on individual and company circumstances, it is necessary to minimize any effects not associated with shift schedule. By adjusting our inclusion criteria, we were able to increase the comparability among groups. Also, the shift history of shift workers over the previous 3 years was confirmed independent of study questionnaires. Daytime workers who had performed shift work in the previous 3 years were excluded from the daytime worker group, allowing us to minimize the effects of previous shift work.
Despite these strengths, this study had some limitations that should be considered when evaluating the results. First, we did not adequately control for some potentially relevant factors associated with hyperhomocysteinemia, particularly workers' diets, which are associated with hyperhomocysteinemia. Hyperhomocysteinemia levels are also related to vitamin B
12, methyltetrahydrofolate and folic acid deficiency [
30]. In this study, information on nutritional deficiency could not be confirmed; however, it was considered unlikely that the workers would exhibit any nutritional deficiencies associated with hyperhomocysteinemia, as all study participants were employees of a large corporation and were not expected to have a low socioeconomic status. Further studies need to consider factors that play important roles in homocysteine metabolism, along with diet information on vitamin B
12, folic acid intake, and the genetics of methyltetrahydrofolate metabolism. While daytime workers with a history of shift work were excluded, we were unable to completely exclude the possibility of previous shift work among current daytime workers. Worker screening included confirmation of work history, as well as determining whether the individual had undergone a medical health examination for night work in the previous 3 years. However, we were unable to confirm whether workers had engaged in shift work previously based on company records. Finally, this study was limited by the cross-sectional nature of its design, as it was based on observational data obtained from health checkups conducted by a single company. Although an association between shift work and hyperhomocysteinemia was confirmed, it remains difficult to draw any definitive conclusion regarding causality.